The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications.
The event will be hosted with the possibility of physical attendance at Evaxion’s facilities in Hørsholm, Denmark and as a live webcast.
Please write to email@example.com with the following details to sign up for the physical attendance for R&D day:
Subject: R&D Day
Message: Your full name
Dr Neergaards Vej 5F,